Hisamitsu Pharmaceutical Co., Inc.

HTSUF · OTC
Analyze with AI
2/28/2025
2/28/2024
2/28/2023
2/28/2022
Assets
Cash & Equivalents$114,518$112,459$122,154$129,290
Short-Term Investments$14,598$12,862$14,714$13,141
Receivables$47,223$42,983$39,753$38,112
Inventory$22,391$21,176$18,922$16,412
Other Curr. Assets$5,058$4,542$3,631$3,221
Total Curr. Assets$203,788$194,022$199,174$200,176
Property Plant & Equip (Net)$59,899$49,462$43,209$39,069
Goodwill$1,294$1,444$0$0
Intangibles$4,679$5,387$945$1,324
Long-Term Investments$71,494$76,813$46,131$39,378
Tax Assets$1,911$0$1,342$1,153
Other NC Assets-$2$1,646$23,113$21,753
Total NC Assets$139,275$134,752$114,740$102,677
Other Assets$5$5$3$5
Total Assets$343,068$328,779$313,917$302,858
Liabilities
Payables$9,910$9,612$14,918$13,225
Short-Term Debt$1,474$1,421$1,398$1,372
Tax Payable$3,627$1,889$2,338$2,938
Deferred Revenue$0$4,539$15,847$11,121
Other Curr. Liab.$32,215$28,477$8,077$3,504
Total Curr. Liab.$47,226$45,938$42,578$32,160
LT Debt$2,382$679$897$1,088
Deferred Rev, NC$0$603$8,408$8,216
Deferred Tax Liab, NC$4,304$4,518$1,813$4,170
Other NC Liab.$9,753$10,559$1,817$2,342
Total NC Liab.$16,439$15,765$12,935$15,816
Other Liabilities$0$0$0$0
Cap. Leases$1,097$953$1,077$1,170
Total Liabilities$63,665$61,703$55,513$47,976
Equity
Pref Stock$0$0$0$0
Common Stock$8,473$8,473$8,473$8,473
Retained Earnings$257,881$242,578$235,569$236,192
AOCI$0$48,455$37,155$25,671
Other Equity$10,468-$34,632-$24,835-$17,171
Total Equity$276,822$264,871$256,362$253,165
Supplemental Information
Minority Interest$2,581$2,205$2,042$1,717
Total Liab. & Tot. Equity$343,068$328,779$313,917$302,858
Net Debt-$110,662-$110,359-$119,859-$126,830